Risk of HIV viral rebound in HIV infected patients on direct acting antivirals (DAAs) treatment for HCV. Morsica G, Galli L, Messina E, Castagna A, et al. PLoS One 2022;17:e0262917.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Morsica G, Galli L, Messina E, Castagna A, et al. Risk of HIV viral rebound in HIV infected patients on direct acting antivirals (DAAs) treatment for HCV. PLoS One 2022;17:e0262917.
PMID: 35113890